Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: First report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741
Marc L. Citron
, Donald A. Berry
, Constance Cirrincione
, Clifford Hudis
, Eric P. Winer
, William J. Gradishar
, Nancy E. Davidson
, Silvana Martino
, Robert Livingston
, James N. Ingle
, Edith A. Perez
, John Carpenter
, David Hurd
, James F. Holland
, Barbara L. Smith
, Carolyn I. Sartor
, Eleanor H. Leung
, Jeffrey Abrams
, Richard L. Schilsky
, Hyman B. Muss
Larry Norton
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: First report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741'. Together they form a unique fingerprint.